Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

TARATARA
22 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PROTARA THERAPEUTICS INC

CITADEL ADVISORS LLC holds 1.2M shares of TARA (PROTARA THERAPEUTICS INC), worth $4.7M as of 2026-Q2. The position was increased (+15.3% shares). TARA represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$4.7M

Current Shares

1.2M

Total Value Change

+$906,635

Total Shares Change

+990,851

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+15.3%
$4.7M0.0%$3.82
31
2026-Q1
Increased
1.1M
+18.5%
$5.6M0.0%$6.15
32
2025-Q4
Increased
901,541
+79.4%
$4.8M0.0%$5.25
41
2025-Q3
Increased
502,454
+21.8%
$2.2M0.0%$4.41
31
2025-Q2
Unchanged
412,531
0.0%
$1.2M0.0%$2.88
0
2025-Q1
Decreased
412,531
-59.9%
$1.8M0.0%$4.58
0
2024-Q4
Increased
1M
+51.0%
$5.4M0.0%$5.28
38
2024-Q3
Increased
680,511
+2.3%
$1.2M0.0%$1.89
26
2024-Q2
Increased
665,372
+2464.3%
$1.4M0.0%$2.08
41
2024-Q1
Decreased
25,948
-31.8%
$104,0510.0%$4.01
0
2023-Q4
Increased
38,035
+71.8%
$71,1250.0%$1.88
22
2023-Q3
Increased
22,143
+121.3%
$36,9790.0%$1.67
22
2023-Q2
Decreased
10,008
-78.3%
$23,9190.0%$2.30
0
2023-Q1
Increased
46,187
+211.1%
$143,1790.0%$3.09
24
2022-Q4
Decreased
14,848
-91.3%
$39,7920.0%$2.68
0
2022-Q3
Decreased
170,522
-29.7%
$505,0000.0%$3.33
0
2022-Q2
Decreased
242,571
-40.3%
$711,0000.0%$2.98
0
2022-Q1
Decreased
406,248
-5.2%
$2.1M0.0%$5.15
0
2021-Q4
Increased
428,366
+23.6%
$2.9M0.0%$6.54
32
2021-Q3
Increased
346,431
+1.3%
$2.4M0.0%$6.85
26
2021-Q2
Increased
342,021
+41.6%
$3.3M0.0%$9.83
35
2021-Q1
New
241,514
-
$3.8M0.0%$14.10
37

Other major holders of TARA: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used